Literature DB >> 6097327

Purine involvement in morphine antinociception.

P Mantegazza, R Tammiso, F Zambotti, L Zecca, N Zonta.   

Abstract

The effects of a series of adenosine derivatives on morphine antinoceptive effect were investigated in rats by the 'tail-flick' method. 2-Chloroadenosine (CADO) and L-N6-phenylisopropyladenosine (L-PIA), given intraperitoneally, caused decreased morphine antinociception. Intracerebroventricular injections of CADO, L-PIA and 5'-N-ethylcarboxamide adenosine (NECA), but not of 2'-deoxyadenosine, antagonized morphine antinociception. The effects of both central and peripheral injections of CADO and L-PIA on morphine antinociception were partially reversed by caffeine. Intracerebroventricular injection of dibutyryl-cyclic 3', 5' adenosine monophosphate (db cyclic AMP) had no effect on morphine antinociception. These data indicate that adenosine plays a role in morphine-induced antinociception. The results are discussed in terms of postulated effects of adenosine derivatives on adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097327      PMCID: PMC1986980          DOI: 10.1111/j.1476-5381.1984.tb16527.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Derivatives of cyclic 3',5'-adenosine monophosphate.

Authors:  T POSTERNAK; E W SUTHERLAND; W F HENION
Journal:  Biochim Biophys Acta       Date:  1962-12-17

2.  Effect of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum.

Authors:  S K Puri; J Cochin; L Volicer
Journal:  Life Sci       Date:  1975-03-01       Impact factor: 5.037

3.  Cyclic adenosine 3',5'-monophosphate in guinea-pig cerebral cortical slices: studies on the role of adenosine.

Authors:  J Schultz
Journal:  J Neurochem       Date:  1975-06       Impact factor: 5.372

4.  Morphine-like drugs inhibit the stimulation of E prostaglandins of cyclic AMP formation by rat brain homogenate.

Authors:  H O Collier; A C Roy
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

5.  Antagonism of morphine analgesia by adenine, adenosine, and adenine nucleotides.

Authors:  D R Gourley; S K Beckner
Journal:  Proc Soc Exp Biol Med       Date:  1973-12

6.  Cyclic adenosine monophosphate antagonism of morphine analgesia.

Authors:  I K Ho; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1973-05       Impact factor: 4.030

7.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.

Authors:  A Sattin; T W Rall
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

8.  Formation of cyclic adenosine 3',5'-monophosphate from adenosine in brain slices.

Authors:  H Shimizu; J Daly
Journal:  Biochim Biophys Acta       Date:  1970-11-24

9.  A simple and inexpensive cannula technique for chemical stimulation of the brain.

Authors:  F B Altaffer; F S Verster; S Hall; C J Long; P D'encarnacao
Journal:  Physiol Behav       Date:  1970-01

10.  Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA).

Authors:  H Vapaatalo; D Onken; P J Neuvonen; E Westermann
Journal:  Arzneimittelforschung       Date:  1975-03
View more
  5 in total

1.  Reversal of the effect of centrally-administered diazepam on morphine antinociception by specific (Ro 15-1788 and Ro 15-3505) and non-specific (bicuculline and caffeine) benzodiazepine antagonists.

Authors:  F Zambotti; N Zonta; R Tammiso; P Ferrario; B Hafner; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

Review 2.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

3.  Pharmacological profiles of opioid ligands at kappa opioid receptors.

Authors:  Parham Gharagozlou; Ezzat Hashemi; Timothy M DeLorey; J David Clark; Jelveh Lameh
Journal:  BMC Pharmacol       Date:  2006-01-25

4.  Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors.

Authors:  Parham Gharagozlou; Hasan Demirci; J David Clark; Jelveh Lameh
Journal:  BMC Neurosci       Date:  2002-11-18       Impact factor: 3.288

5.  Activity of opioid ligands in cells expressing cloned mu opioid receptors.

Authors:  Parham Gharagozlou; Hasan Demirci; J David Clark; Jelveh Lameh
Journal:  BMC Pharmacol       Date:  2003-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.